Preoperative imaging of Charcot neuroarthropathy: Does the additional application of 18F-FDG-PET make sense?;Präoperative bildgebung bei diabetisch-neuropathischer osteoarthropathie: Ist der zusätzliche einsatz von 18F-FDG-PET sinnvoll?

NuklearMedizin

Volumn 45, Issue 1, 2006, Pages 15-20

  Höpfner, Stefan ^a   Krolak, C ^b   Kessler, S ^b   Tiling, R ^b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bone detritus; Diabetic neuropathic osteoarthropathy; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GLUCOSE METABOLISM; HUMAN; JOINT SURGERY; MALE; NEUROPATHIC JOINT DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RADIODIAGNOSIS; DIABETIC ANGIOPATHY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PREOPERATIVE CARE; SCINTISCANNING;

DIABETIC ANGIOPATHIES; FLUORODEOXYGLUCOSE F18; GAIT DISORDERS, NEUROLOGIC; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS;

EID: 33646906609     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623931     Document Type: Article

References (18)

1. 18F-FDG positron emission tomography to differentiate diabetic osteoarthropathy from septic arthritis. Clin Nucl Med 2001; 26: 638-9.
2. Berendt AR, Lipsky B. Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot. Curr Diab Rep 2004; 4: 424-9.
3. Frykberg RG, Armstrong DG, Giurini J et al. American College of Foot and Ankle Surgeons. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg 2000; 39: 1-60.
4. st Scientific Symposium. J Am Podiatr Med Assoc 2002; 92: 2-6.
5. Gil HC, Morrison WB. MR imaging of diabetic foot infection. Semin Musculoskelet Radiol 2004; 8: 189-98.
6. Green MF, Aliabadi Z, Green BT. Diabetic foot: evaluation and management. South Med J 2002; 95: 95-101.
7. 18F-FDG PET/CT. J Nucl Med 2005; 46: 444-9.
8. Kessler SB, Kalteis TA, Botzlar A. Principles of surgical treatment of diabetic neuropathic osteoarthropathy. Internist 1999; 40: 1029-35.
9. Kessler SB, Kreuz PC. Diabetic foot syndrome. When is surgery reliable and necessary? MMW Fortschr Med 2001; 143: 34-6.
10. Lipman BT, Collier BD, Carrera GF et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography. Clin Nucl Med 1998; 23: 77-82.
11. Maugendre D, Poirier JY. Nuclear medicine in the diagnosis of diabetic foot osteomyelitis. Diabetes Metab 2001; 27: 396-400.
12. Morrison WB, Ledermann HP, Schweitzer ME. MR imaging of the diabetic foot. Magn Reson Imaging Clin N Am 2001; 9: 603-13.
13. Rajbhandari SM, Jenkins RC, Davies C et al. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 45: 1085-96.
14. Ruemenapf G, Neufang A, Schmiedt W et al. Gefäßchirurgie bei Diabetikern mit Fußproblemen. Dtsch Arztebl 2004; 101: A3348-54.
15. Sommer TC, Lee TH. Charcot foot: the diagnostic dilemma. Am Fam Physician 2001; 64: 1591-8.
16. Sugawara Y, Braun DK, Kison PV et al. Rapid detection of human infections witf fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25: 123-43.
17. Vesco L, Boulahdour H, Hamissa S et al. The value of combined radionuclide and magnetic resonance imaging in the diagnosis and conservative management of minimal or localized osteomyelitis of the foot in diabetic patients. Metabolism 1999; 48: 922-7.
18. Wegener WA, Alavi A. Diagnostic imaging of musculoskeletal infection. Roentgenography; gallium, indium-labeled white blood cell, gammaglobulin, bone scintigraphy; and MRI. Orthop Clin North Am 1991; 22: 401-18.